loadpatents
name:-0.032208919525146
name:-0.025973081588745
name:-0.018527984619141
Helal; Christopher John Patent Filings

Helal; Christopher John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Helal; Christopher John.The latest application filed is for "novel imidazo[4,5-c]quinoline derivatives as lrrk2 inhibitors".

Company Profile
19.30.34
  • Helal; Christopher John - Mystic CT
  • - Mystic CT US
  • Helal; Christopher John - East Lyme CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors
Grant 11,312,713 - Brodney , et al. April 26, 2
2022-04-26
Novel Imidazo[4,5-c]quinoline Derivatives As Lrrk2 Inhibitors
App 20210355117 - BRODNEY; Michael Aaron ;   et al.
2021-11-18
Cyclic substituted imidazo[4,5-c]quinoline derivatives
Grant 11,161,844 - Chappie , et al. November 2, 2
2021-11-02
Piperazine Azaspiro Derivaves
App 20210024497 - Zhang; Lei ;   et al.
2021-01-28
Heterocyclic spiro compounds as MAGL inhibitors
Grant 10,858,373 - Brodney , et al. December 8, 2
2020-12-08
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
Grant 10,738,063 - Chappie , et al. A
2020-08-11
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
Grant 10,723,711 - Butler , et al.
2020-07-28
Imidazopyridazine compounds
Grant 10,669,279 - Chappie , et al.
2020-06-02
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors
Grant 10,626,125 - Brodney , et al.
2020-04-21
Cyclic Substituted Imidazo[4,5-c]quinoline Derivatives
App 20200039977 - Chappie; Thomas Allen ;   et al.
2020-02-06
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives And 1,1,1-trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives As Magl
App 20190382359 - BUTLER; CHRISTOPHER RYAN ;   et al.
2019-12-19
Imidazopyridazine Compounds
App 20190322674 - Chappie; Thomas Allen ;   et al.
2019-10-24
6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide Compounds
App 20190300546 - Chappie; Thomas Allen ;   et al.
2019-10-03
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
Grant 10,428,034 - Butler , et al. October 1, 2
2019-10-01
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives As Magl Inhibitors
App 20190276472 - BRODNEY; MICHAEL AARON ;   et al.
2019-09-12
Tricyclic Compounds And Their Use As Phosphodiesterase Inhibitors
App 20190263816 - Chappie; Thomas Allen ;   et al.
2019-08-29
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors
Grant 10,329,308 - Brodney , et al.
2019-06-25
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
Grant 10,323,042 - Chappie , et al.
2019-06-18
6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide Compounds
App 20190055262 - Chappie; Thomas Allen ;   et al.
2019-02-21
Imidazopyridazine Compounds
App 20180346475 - Chappie; Thomas Allen ;   et al.
2018-12-06
Pyrazolopyrimidine compounds
Grant 10,131,669 - Chappie , et al. November 20, 2
2018-11-20
Imidazopyridazine compounds
Grant 10,077,269 - Chappie , et al. September 18, 2
2018-09-18
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives As Magl Inhibitors
App 20180208607 - BRODNEY; MICHAEL AARON ;   et al.
2018-07-26
Heterocyclic Spiro Compounds As Magl Inhibitors
App 20180208608 - BRODNEY; MICHAEL AARON ;   et al.
2018-07-26
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
App 20180200253 - COE; JOTHAM WADSWORTH ;   et al.
2018-07-19
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives And 1,1,1-trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives As Magl Inhibitors
App 20180065943 - BUTLER; CHRISTOPHER RYAN ;   et al.
2018-03-08
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
Grant 9,845,301 - Butler , et al. December 19, 2
2017-12-19
Pyrazolopyrimidine Compounds
App 20170204099 - Chappie; Thomas Allen ;   et al.
2017-07-20
Imidazopyridazine Compounds
App 20170145022 - Chappie; Thomas Allen ;   et al.
2017-05-25
Imidazopyridazine compounds
Grant 9,598,421 - Chappie , et al. March 21, 2
2017-03-21
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives And 1,1,1-trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives As Magl Inhibitors
App 20170029390 - BUTLER; CHRISTOPHER RYAN ;   et al.
2017-02-02
Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
Grant 9,550,795 - Brodney , et al. January 24, 2
2017-01-24
Triazine derivatives
Grant 9,296,761 - Chappie , et al. March 29, 2
2016-03-29
Imidazopyridazine Compounds
App 20160039828 - Chappie; Thomas Allen ;   et al.
2016-02-11
Triazine Derivatives
App 20150353579 - Chappie; Thomas Allen ;   et al.
2015-12-10
Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
Grant 9,200,000 - Helal , et al. December 1, 2
2015-12-01
Triazine derivatives
Grant 9,145,427 - Chappie , et al. September 29, 2
2015-09-29
Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds
App 20150087637 - Brodney; Michael Aaron ;   et al.
2015-03-26
Triazine Derivatives
App 20150080401 - Chappie; Thomas Allen ;   et al.
2015-03-19
Triazine derivatives
Grant 8,933,224 - Chappie , et al. January 13, 2
2015-01-13
Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
Grant 8,933,221 - Brodney , et al. January 13, 2
2015-01-13
Triazine Derivatives
App 20140329820 - Chappie; Thomas Allen ;   et al.
2014-11-06
Pyrazolo[3,4-d]pyrimidine compounds and their use as PDE2 inhibitors and/or CYP3A4 inhibitors
Grant 8,829,010 - Helal , et al. September 9, 2
2014-09-09
Amino-Heterocyclic Compounds
App 20140088081 - Claffey; Michelle Marie ;   et al.
2014-03-27
Pyrazolo[3,4-d]pyrimidine Compounds And Their Use As Pde2 Inhibitors And/or Cyp3a4 Inhibitors
App 20140080806 - Helal; Christopher John ;   et al.
2014-03-20
Imidazo[5,1-f][1,2,4]Triazines For The Treatment of Neurological Disorders
App 20140066622 - Helal; Christopher John ;   et al.
2014-03-06
Amino-heterocyclic compounds
Grant 08618117 -
2013-12-31
Amino-heterocyclic compounds
Grant 8,618,117 - Claffey , et al. December 31, 2
2013-12-31
Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
Grant 8,598,155 - Helal , et al. December 3, 2
2013-12-03
Novel Sultam Compounds
App 20130150376 - Brodney; Michael Aaron ;   et al.
2013-06-13
Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds
App 20130053373 - BRODNEY; Michael Aaron ;   et al.
2013-02-28
Amino-Heterocyclic Compounds
App 20120329777 - Claffey; Michelle Marie ;   et al.
2012-12-27
Imidazo[5,1-f][1,2,4]Triazines for the Treatment of Neurological Disorders
App 20120214791 - HELAL; Christopher John ;   et al.
2012-08-23
11C-labeled benzyl-lactam compounds and their use as imaging agents
Grant 8,012,969 - Helal , et al. September 6, 2
2011-09-06
Benzyl(idene)-lactam derivatives
Grant 7,479,559 - Brodney , et al. January 20, 2
2009-01-20
11C-Labeled Benzyl-Lactam Compounds and Their Use as Imaging Agents
App 20080206137 - Helal; Christopher John ;   et al.
2008-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed